NCT02675829 2026-03-04Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant CancersMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting131 enrolled
NCT03420963 2026-03-03Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid TumorsM.D. Anderson Cancer CenterPhase 1 Terminated12 enrolled